1-7 of 7
patient-focused outcomes
Close
Sort by
Journal Articles

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

David C. Fajgenbaum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 318–325.
https://doi.org/10.1182/asheducation-2018.1.318
Published: 2018
Journal Articles

Treatments targeting MDS genetics: a fool’s errand?

Amy E. DeZern
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 277–285.
https://doi.org/10.1182/asheducation-2018.1.277
Published: 2018
Journal Articles

Challenges and implications of genomics for T-cell lymphomas

Eric D. Jacobsen, David M. Weinstock
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 63–68.
https://doi.org/10.1182/asheducation-2018.1.63
Published: 2018
Journal Articles

Nine years without a new FDA-approved therapy for MDS: how can we break through the impasse?

Amy E. DeZern
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 308–316.
https://doi.org/10.1182/asheducation-2015.1.308
Published: 2015
Journal Articles

When, how, and what cell source for hematopoietic cell transplantation in first complete remission adult acute lymphoblastic leukemia?

Hillard M. Lazarus, Anjali S. Advani
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 382–388.
https://doi.org/10.1182/asheducation.V2012.1.382.3798359
Published: 2012
Journal Articles

Immunoregulatory Effects of Stored Red Blood Cells

Karina Yazdanbakhsh, Weili Bao, Hui Zhong
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 466–469.
https://doi.org/10.1182/asheducation-2011.1.466
Published: 2011
Journal Articles

Upcoming Diagnostic and Therapeutic Developments in Classical Hodgkin's Lymphoma

Kristie A. Blum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 93–100.
https://doi.org/10.1182/asheducation-2010.1.93
Published: 2010